Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Operating Expenses | 3 | 7 | 14 | 3 | 15 |
| Operating Income | -3 | -7 | -14 | -3 | -15 |
| Pre-tax Income | -3 | -7 | -14 | -3 | -15 |
| Net Income Continuous | -3 | -7 | -14 | -3 | -15 |
| Net Income | $-3 | $-7 | $-14 | $-3 | $-15 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.15 | -0.05 | -0.30 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.80 | -0.05 | -0.30 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.15 | -0.05 | -0.30 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.80 | -0.05 | -0.30 |
| EBITDA(a) | $-3 | $-6 | $-14 | $-2 | $-15 |